COVID-19

Gilead Sciences' remdesivir is the first drug to receive FDA approval for treating COVID-19 in the United States.

Thirty-four percent of people in Turkey and 17% of people in the UK report that they are “hesitant” about a COVID-19 vaccine, primarily based on the their beliefs regarding the origin of the virus.

Patients with current or former smoking status may be at an increased risk of severe illness due to COVID-19.

Physicians and scientists tested several oral and nasopharyngeal rinses in a laboratory setting for their ability to inactivate human coronaviruses that are similar in structure to SARS-CoV-2.

According to Amy Kallo, a PharmD student at Midwestern University, working at a pharmacy during the pandemic helped to solidify her understanding of the role of pharmacists as educators in their communities.

Barring a successful vaccine, COVID-19 may experience a yearly outbreak similar to the flu.

An expert panel discussed the changes to their businesses, due to the COVID-19 pandemic, and what they think the future holds for specialty pharmacy.

The trial’s main goal is to compare the health status of participants in the combination treatment group with participants in the remdesivir-only group on day 7.

The US Department of Health & Human Services released guidance at the beginning of the pandemic clarifying guidelines regarding best practices in HIV care.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.

Lennartz said it’s important that pharmacists are properly reimbursed for the administration of many common immunizations, including the flu vaccine.

Virtual transitions of care services are a valuable and viable opportunity for students to progress to graduation and gain valuable experience in preparation for professional employment.

Study shows a small increase in the perceived reliability of COVID-19 conspiracies equates to a larger drop in the intention to get vaccinated.

The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.

Pharmacy Times® interviewed Petros Grivas, associate professor at the University of Washington and Fred Hutchinson Cancer Research Center and a medical oncologist at Seattle Cancer Care Alliance, on the value of the pharmacist in the treatment of patients with cancer during COVID-19.

In a short time, COVID-19 has increased our dependency on technology and pharmaceutical companies are actively investigating this digital transformation.

Top news of the week from Pharmacy Times.

Many manufacturers are making headway in the race for a COVID-19 vaccine, with about 5 players in phase 3 trials.

Hospitalized patients with COVID-19 treated with enoxaparin were found to have lower rates of thrombosis, kidney injury, and mortality than patients treated with unfractionated heparin.

Age has been connected to symptom severity and mortality in COVID-19, however, it does not affect susceptibility to infection with the virus.

Although researchers still hope to learn what protection immunoglobulin G antibodies offer against re-infection, this study could have broad implications in the development of a COVID-19 vaccine.

One in 4 adults reported a change in alcohol use almost immediately after stay-at-home orders were issued during the coronavirus disease 2019 pandemic.

The combination of isolating potentially sick patients in their car and conducting the test in a ventilated setting minimizes COVID-19 transmission to the rest of the population.

The physical and emotional stress of a COVID-19 diagnosis might be the triggering factor for the development of herpes zoster ophthalmicus.

Investigators found a link between the sleep quality of mother and child related to the COVID-19 pandemic.